Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysarthria, Infarction, Muscular Disorders, Atrophic, Necrosis, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, articulation disorder, brain disorder, brain infarction, brain ischemia, brain stem infarction, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, hereditary disease, injury, ischemic disease, language disorder, locked-in syndrome, metabolic disease, motor neuron disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, palsy, proteostasis deficiencies, quadriplegia, speech disorder, spinal cord disorder, spinal cord injury, stroke disorder, vascular disorder	Recruiting	Not applicable	2025-12-01		NCT06094205

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Leigh R. Hochberg, MD, PhD.	5
National Institute on Deafness and Other Communication Disorders (NIDCD)	187

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, Davis	Sacramento	United States	49